CoChat

Relief from profound fatigue associated with chronic liver disease by long‐term ondansetron therapy

Jones, E Anthony · 1999 · The Lancet

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

A woman with chronic hepatitis C and profound fatigue became symptomfree when treated long-term with ondansetron 4 mg twice daily. Altered central serotoninergic neurotransmission may contribute to fatigue complicating chronic liver disease.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(99)02936-0

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cited by

See all 66

Metadata

Authors
Jones, E. A.
Affiliations
Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Jones, E Anthony
Venue
The Lancet
Publisher
Elsevier BV
Published
1999-07
Volume
354
Issue
9176
Pages
397
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2109673420
Cited by
66
References
6
Citations by year
2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2015: 1 · 2012: 6
FWCI
1.73
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
ondansetron, chronic fatigue, chronic hepatitis C, chronic liver disease, serotonergic neurotransmission, long-term drug therapy, symptom relief
MeSH terms
Adult, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Fatigue, Female, Humans, Liver Function Tests, Serotonin Antagonists, Ondansetron, Hepatitis C, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relief from profound fatigue associated with chronic liver disease by long‐term ondansetron therapy. https://app.cochat.ai/papers/10.1016/s0140-6736(99)02936-0
The paper
Jones, E. A. (1999). Relief from profound fatigue associated with chronic liver disease by long‐term ondansetron therapy. The Lancet. https://doi.org/10.1016/s0140-6736(99)02936-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.